Total
USD $0.00
« Back to previous page

Czech Republic Pharma and Healthcare Sector Report 2019/2020

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: March 2019
Pages: 78
Available in: English

The gross value added (GVA) of the Czech pharmaceutical sector amounted to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector accounted for 0.4% of the GDP that year. The pharmaceutical sector employed 9,855 workers in 2017, accounting for 0.2% of the total number of employees. Total healthcare expenditures amounted to CZK 358.8bn in 2017, increasing by 5.3% y/y, according to OECD data. The increase was mainly due to public healthcare expenditures, which rose by 4% y/y to CZK 293.3bn, having a share of 81.7% of total healthcare expenditures. Total healthcare expenditures accounted for 7.1% of GDP in 2017. The human health and social work activities employed 294,300 people in 2017, accounting for 7.3% of the total employment in the country.  

 

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for the Czech Republic . EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in the Czech Republic
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in the Czech Republic
  • Crystallise the forces both driving and restraining this sector in the Czech Republic
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in the Czech Republic
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).

 

See below for a complete table of report contents:

Czech Republic Pharma and Healthcare Sector Report 2019/2020 - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

Czech Republic Pharma and Healthcare Sector Report 2019/2020 -  Page 3
Czech Republic Pharma and Healthcare Sector Report 2019/2020 -  Page 4
Czech Republic Pharma and Healthcare Sector Report 2019/2020 -  Page 19
Czech Republic Pharma and Healthcare Sector Report 2019/2020 -  Page 62
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?